A1 Biochem Labs LLC
Wilmington, NC
- UEI
- H5YCMCNUELL1
- CAGE
- 7SAC1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5598 Marvin K Moss Ln Suite #2017, Wilmington, NC 28409, USA
- Website
- a1biochemlabs.com
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $69,352 |
| FY2025 | $6,012 |
| FY2024 | $24,852 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $69,352 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Chemogenics Biopharma, LLC | Durham, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Karebay Biochem Inc. | Fredonia, NY | 325199 All Other Basic Organic Chemical Manufacturing |
| Enamine US Inc. | South Brunswick Township, NJ | 424690 Other Chemical and Allied Products Merchant Wholesalers |
| Richman Chemical, Inc. | Spring House, PA | 325199 All Other Basic Organic Chemical Manufacturing |
| Cayman Chemical Co Inc. | Ann Arbor, MI | 325199 All Other Basic Organic Chemical Manufacturing |
About the company
A1 Biochem Labs LLC, a small-business, for-profit limited liability company headquartered in Wilmington, North Carolina, supplies custom-synthesized organic chemical compounds and intermediates to federal research institutions as a prime contractor on full-and-open purchase orders, with no set-aside activity and no subcontract relationships. The vendor operates exclusively as a prime across its federal footprint.
A1 Biochem's customer base concentrates entirely within the Department of Health and Human Services National Institutes of Health. The National Center for Advancing Translational Sciences accounts for three awards with $207 thousand combined potential value; the National Heart Lung and Blood Institute holds three awards with $51 thousand combined potential value; and the National Institute on Drug Abuse placed two awards with $23 thousand combined potential value — together covering 100% of the vendor's federal award portfolio. Representative work includes a $69,352 purchase order from NCATS (awarded September 11, 2026, completion February 26, 2027) for synthesis of five custom chemical compounds supporting Ewing sarcoma research at minimum 95% purity with Certificates of Analysis; a $24,852 NCATS purchase order (August 29, 2024) for non-GMP scale-up synthesis of a benzo-imidazole derivative; a $14,562 National Heart Lung and Blood Institute purchase order (January 3, 2025) for the specialized NHC ligand 1,3-dimesityl-4,5-bis(tridecafluorooctyl)-4,5-dihydro-1H-imidazol-3-ium chloride supporting the SABRE project; and a $112,350 NCATS purchase order (July 28, 2022, set aside for Total Small Business and part of the Coronavirus COVID-19 response effort) for 34 intermediate compounds in 5-gram quantities with greater than 95% purity.
Award activity is sparse and episodic — one award per year from 2020 through 2026, with eight total awards since 2017 and a combined obligated value of $280 thousand. One award ($69 thousand) reaches ultimate completion within the next twenty-four months. The vendor's NAICS footprint splits across organic chemical manufacturing (2 awards), research and development in physical engineering and life sciences (2 awards), pharmaceutical preparation manufacturing, miscellaneous chemical products, and testing services. PSC codes align with chemicals (4 awards), reference laboratory testing (2 awards), and drugs and biologicals. Service Contract Inventory records show 12.7 FTEs in FY2024 and 14.3 FTEs in FY2025, all SCI-reported activity routed through A1 Biochem as a named subcontractor on four records — indicating that SCI captures only a subset of the vendor's federal chemistry work, which flows primarily through small-dollar purchase orders outside the SCI reporting threshold.
Quick answers
Is A1 Biochem Labs LLC registered in SAM.gov?
Yes. A1 Biochem Labs LLC's SAM.gov registration is active through October 5, 2027.
What is A1 Biochem Labs LLC's CAGE code?
A1 Biochem Labs LLC's CAGE code is 7SAC1, and its Unique Entity ID (UEI) is H5YCMCNUELL1.
How much has A1 Biochem Labs LLC received in federal contracts?
Federal contracts obligated $6,012 to A1 Biochem Labs LLC in fiscal year 2025 and $100,216 in fiscal years 2023 through 2027.
What is A1 Biochem Labs LLC's most recent federal award?
A1 Biochem Labs LLC's most recent federal contract award is Ncats: service: synthesis of compounds and intermediates: severable (75N98026P01597), from Office of Logisitics and Acquisition Operations (NIH), on September 11, 2026.
On GovTribe
See A1 Biochem Labs LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors